Volume 31, Number 11—November 2025
Research
Monkeypox Virus Partial-Genome Amplicon Sequencing for Improvement of Genomic Surveillance during Mpox Outbreaks
Table 4
Genetic variants over the 10-kb and 15-kb genomic regions of MPXV in 36 clinical specimens for study of partial-genome amplicon sequencing for improvement of genomic surveillance during mpox outbreaks*
| Specimen no. | Country | sSNP | nsSNP | Total SNPs† | Indels | Variants‡ | SNP type§ | SNPs |
|---|---|---|---|---|---|---|---|---|
| 1–20 | USA | 15 | 27 | 42 | 2 | 44 | GA>AA | 17 |
| Other |
25 |
|||||||
| 21–30 | DRC | 90 | 17 | 107 | 20 | 127 | GA>AA | 22 |
| Other |
85 |
|||||||
| 31–36 | DRC | 60 | 10 | 70 | 7 | 77 | GA>AA | 23 |
| Other | 47 |
*See Table 1. DRC, Democratic Republic of the Congo; indels, insertions and deletions; MPXV, monkeypox virus; nsSNP: nonsynonymous SNP; SNP, single-nucleotide polymorphism; sSNP, synonymous SNP. USA, United States. †Total number of SNPs include sSNP and nsSNPs. ‡Variants include total number of SNPs plus indels. §SNP type GA>AA (5′–3′) includes TC>TT (5′–3′).
Page created: November 18, 2025
Page updated: December 10, 2025
Page reviewed: December 10, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.